Francis Ouellette: Investigator & Associate Director, Informatics and Bio-computing, Ontario Institute for Cancer Research
Francis Ouellette is an Investigator and the Associate Director for the Informatics and Bio-computing platform at the Ontario Institute for Cancer Research. He is also Associate Professor in the Department of Cell and Systems Biology at the University of Toronto and the Scientific Coordinator of the Canadian Bioinformatics Workshop series. In his work Francis deals with cancer genomic data, which are large and complex datasets, generated at the OICR. This work requires new computational methods. The Informatics and Bio-computing Platform develops new algorithms, software, databases, visualization tools and other necessary components to interpret these datasets. OICR shares its resources with scientists worldwide, in its goal to translate cancer research and results to the clinic.
Paul Terry: President & CEO, PHEMI Health Systems
Dr. Paul Terry is the President & CEO at PHEMI Health Systems, a board member at Providence Health Care, one of the Entrepreneurs-in-Residence at SFU Venture Labs and a Partner with Magellan Angel Partners. For the past 11 years, he was also the secretary/treasurer and technology adviser for the Michael Smith Foundation for Health Research, BC’s health research support agency. Prior to this, Paul was the CTO and cofounder of OctigaBay Systems – a pioneer in high performance computing – which was acquired by Cray Inc. He was also the cofounder and CTO of Abatis Systems, which was acquired by Redback Networks in one of the largest technology acquisitions in Canadian history. Paul’s early career included senior roles at Newbridge Networks and at technology companies in the UK. Paul was awarded Canada’s “Top 40 Under 40″ award in 2000. He holds an MBA from the Cranfield School of Management, a marketing diploma from the Chartered Institute of Marketing, a PhD in Electrical Engineering and an honors Bachelor’s degree from the University of Liverpool. PHEMI Health Systems is a process automation and analytics company that unlocks patient data to improve clinic productivity, patient outcomes, and medical research.
Ryan D’Arcy: BC Leadership Chair in Medical Technology
Ryan D’Arcy is a neuroscientist and renowned expert in translating brain imaging advances into health care innovations.
Dr. D’Arcy received his B.Sc. from University of Victoria (with distinction), M.Sc. & Ph.D. in Neuroscience from Dalhousie University, and completed post-doctoral training in Medical Technologies at the National Research Council (NRC). He then went on to establish the world-renowned NRC Institute for Biodiagnostics (Atlantic) in Halifax. As the Institute’s head and senior research officer, Dr. D’Arcy attracted over $50 million in investments in advanced biomedical imaging and established a critical mass of scientists, engineers, and clinicians focused on health technology advances in the diagnosis and treatment of neurological patients. He led the local hospitals and the university towards “innovations from imaging” and has been widely credited for helping to catalyze Atlantic Canada’s thriving medical technology cluster. He has over 150 published works, has been named a “Kickass Canadian,” and has several emerging technology products to help people manage devastating impacts of brain diseases and disorders.
Dr. D’Arcy is the chief inventor and architect of the Halifax Consciousness Scanner (HCS)—a portable brain vital sign scanner proven invaluable for evaluating major brain trauma and concussion. The HCS technology has been licensed to Mindful Scientific where Dr. D’Arcy continues to play a key role as chief scientific advisor. He is an expert in advanced magnetic resonance imaging (MRI) and led the development of an innovative monitoring application that helped Captain Trevor Greene recover following a devastating brain injury in Afghanistan. D’Arcy also led the development and pioneering demonstration of the world’s first virtual reality rehearsal for removal of a brain tumour. The brain surgery simulator, NeuroTouch, is now marketed and deployed worldwide. Working with a BC company, Conquer Mobile, his latest work involves the development of a suite of virtual reality surgical simulation training products.
Currently, Dr. D’Arcy serves as Professor and BC Leadership Chair in Medical Technologies for Simon Fraser University and Surrey Memorial Hospital Foundation and Head of Health Sciences and Innovation at Fraser Health’s Surrey Memorial Hospital. Dr. D’Arcy has joined forces with the City of Surrey to drive the rapid development of Surrey’s Innovation Boulevard, which will focus BC’s technology sector into a global leader of health care innovation.
Rupert Potter: Consul-General of the United Kingdom, Vancouver
Rupert Potter took up his position as British Consul General in Vancouver on July 13, 2012 and is the British government’s representative in British Columbia, the Yukon and the North West Territories. His wife and two children join him in Vancouver. Born in Australia, Rupert joined the Foreign and Commonwealth Office (FCO) in 1992 after graduating from St Andrews University with an MA with honours in Modern History with International Relations. Immediately prior to his posting in Vancouver, Rupert served as the Deputy Head of Mission in Bahrain from 2008 to 2012. He has also served overseas as Vice Consul at the British Embassy in Jordan from 1995 to 1998, and in the political section of the British Embassy in Sweden from 1999 to 2002. In London, he has worked for the FCO’s South Asia Department, Afghanistan Unit and North America Department, as well as working for Cabinet Office and taking a secondment with the International Institute for Strategic Studies (IISS). In 2005 he also completed his second MA, in Creative Writing, at the University of East Anglia.
Dan Goldowitz: Co-Director, Center for Molecular Medicine and Therapeutics
Dan Goldowitz received his PhD in Psychobiology at the University of California at Irvine with a thesis that focused on the plasticity of the adult central nervous in response to lesions. His subsequent postdoctoral work at Harvard Children’s Hospital in Boston, the Karolinska Institute in Stockholm, and the University of Utah School of Medicine in Salt Lake City was in the development of the nervous system. His first position was as an assistant professorship at Jefferson Medical School in Philadelphia. Using approaches that were relatively novel to the study of the brain he pioneered approaches to ascertain the function of genes in brain and behaviour. He moved to the University of Tennessee Health Science Centre (UTHSC) in Memphis and was a leading force in organizing researchers across the State of Tennessee in forming a collaborative to use the mouse as a model organism to identify the function of the genes that were just being uncovered with the human genome project.
Shurjeel Choudhri: Senior VP and Head, Medical and Scientific AffairsBayer Inc.
Dr. Choudhri joined Bayer Corporation in 1999 and has had significant experience with the Bayer US medical and Global Development organizations. Before assuming his current role as Head of Medical and Scientific Affairs (M&SA) in Canada, Dr. Choudhri was the Global Clinical Leader, Anti-Infectives with the Bayer Global Clinical Development group. As Head of M&SA for Bayer Inc Dr. Choudhri is responsible for contributing to the Canadian and International development, registration, and post-registration scientific/medical support for Bayer’s pharmaceutical products. Dr. Choudhri obtained his MD from the University of Manitoba and also did his specialty training in Internal Medicine and sub-speciality training in Infectious Diseases in Manitoba. He then completed a senior research fellowship in Nairobi, Kenya and in1996 was awarded the Young Investigator Award by the Canadian Association of HIV Researchers. Dr. Choudhri has authored or co-authored over 100 scientific abstracts and has contributed to over 40 publications in peer reviewed journals. Prior to joining Bayer, he was an Assistant professor in the Departments of Medical Microbiology and Internal Medicine at the University of Manitoba, Director of the HIV/AIDS program at the St. Boniface General Hospital and the Manitoba Satellite Director for the Canadian HIV Clinical Trials Network.
Harry Kim: Senior Director, Enterprise Services, WW Healthcare Strategy and Portfolio, HP
Harry Kim leads HP’s worldwide strategy and solutions portfolio for the Enterprise Services Healthcare industry. During Kim’s tenure, HP has outgrown the competition to become the #1 technology leader in HLS, an estimated $10.6 billion dollar plus industry vertical, according to industry analysts. HP recognizes the emerging transformation across the value chain of biosciences research, pharmaceutical, healthcare provider and healthcare payer organizations. Kim has been instrumental in the strategy development and growth of this industry vertical. His areas of responsibility include: driving market awareness, fueling growth through new solutions, expanding global ES footprint, defining sales enablement programs, and supporting global delivery. Previously, Kim was director of strategy for HP’s Public Sector segment, an $11 billion dollar plus industry vertical for HP. Prior to that, Kim served as director in HP’s Strategy and Corporate Development group focused on driving cross-company growth initiatives such as Wellness and Homeland Security.
Diane Finegood: President & CEO, Michael Smith Foundation for Health Research
As president & CEO of the Michael Smith Foundation for Health Research, Dr. Diane Finegood draws on an exceptional record of academic and leadership experience to champion the growth of British Columbia’s health research enterprise. From 2000 to 2008, Diane served as the inaugural scientific director of the Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism & Diabetes, where she led the focus on the strategic priority of obesity and healthy body weight. She also served as executive director of the CAPTURE Project (Canadian Platform to Increase Usage of Real-World Evidence), where she led a national strategic initiative to build a system to support the collection and use of practice-relevant evidence. Diane is an internationally recognized scientist, innovator, communicator, strategic visionary, and proven leader in health research. As a scientist, she has made seminal contributions to our understanding of the causes of diabetes through the use of mathematical modeling. Her recent work has focused on understanding the complex biological, social, cultural, and environmental systems involved in regulation of body weight in individuals and populations. Among her numerous honours and recognitions, Diane has received the Canadian Obesity Network’s Mentorship Award (2011), the Canadian Diabetes Association’s Frederick G. Banting Award (2008), and was named one of Canada’s 100 Most Powerful Women by Women’s Executive Network (2006). Diane obtained her doctoral degree in physiology and biophysics from the University of Southern California and has a bachelor’s and master’s degree in engineering from the University of Michigan and Northwestern University. She is a professor in the Department of Biomedical Physiology & Kinesiology at Simon Fraser University.
Terry Lake: Minister of Health, Province of British Columbia
Terry Lake was re-elected as MLA for Kamloops-North Thompson on May 14, 2013. He was appointed Minister of Health on June 10, 2013. Terry currently chairs the Cabinet Committee on Secure Tomorrow, serves as vice-chair of the Treasury and is a member of the Cabinet Working Group on Core Review. Previously, he served as Minister of Environment. He also enjoyed stints as Parliamentary Secretary for Health Promotion to the Minister of Health Services, and Parliamentary Secretary for the Ranching Task Force to the Minister of Agriculture and Lands. Terry has also served on the Select Standing Committees for Aboriginal Affairs, Health, and Legislative Initiatives. He was also a member of the Early Childhood Education Innovations Committee. Terry was the Mayor of Kamloops from 2005-2008, and a city councillor from 2002-2005. He is a former Vice-President of the Union of BC Municipalities, and a former member of the BC Transit Board of Directors. A veterinarian by profession, Terry is a recipient of the BC Veterinary Medical Association Award of Merit for Service and is a former Vice-President of the World Small Animal Veterinary Association. Terry and his wife Lisa have three daughters, a dog and a cat.
Joel Dudley: Assistant Professor of Genetics / Genomic Sciences & Director of Biomedical Informatics, Mount Sinai School of Medicine
Dr. Joel Dudley is Assistant Professor of Genetics and Genomic Sciences and Director of Biomedical Informatics at Mount Sinai School of Medicine. His current research is focused towards solving key problems in genomic and systems medicine through the development and application of translational and biomedical informatics methodologies. Dr. Dudley’s published research covers topics in bioinformatics, genomic medicine, personal and clinical genomics, as well as drug and biomarker discovery. His recent work with co‐authors describing a novel systems based approach for computational drug repositioning was featured in the Wall Street Journal, and earned designation as the NHGRI Director’s Genome Advance of the Month. He is also co-‐author (with Konrad Karczewski) of the book, Exploring Personal Genomics, which is the first major text on personal genome analysis and interpretation. Dr. Dudley received a B.S. in Microbiology from Arizona State University and an M.S. and Ph.D. in Biomedical Informatics from Stanford University School of Medicine.
Dinesh Sharma Vice President, Corporate Innovation, SAP
At SAP, we believe that there is a great opportunity to enhance and accelerate innovation efforts by teaming up with world-class innovators from outside, and inside, the company. Dinesh leads a group that seeks to build unconventional partnerships with global companies and deliver breakthrough innovation that can form the basis for meaningful benefits for consumers and partners alike. Dinesh is an experienced technology executive in both enterprise and startup domains. His experience spans leading engineering, marketing, all the way up to running worldwide business units for large technology companies. Dinesh spent more than 20 years working in the professional computer graphics domain leading efforts in semiconductors as well as software at companies such as Dynamic Pictures, ATI and AMD. In the past 5 years he has been in leadership roles at startups in the virtualization, big data and distributed computing spaces with a heavy emphasis on building Cloud infrastructure and platforms. He holds a B. Eng. from University of Liverpool in UK and lives in the San Francisco Bay Area with his wife and two small children.
Greg D’Avignon: President and Chief Executive Officer Business Council of British Columbia
Greg D’Avignon is the President and Chief Executive Officer of the Business Council of British Columbia, a 260-member organization comprised of the province’s leading businesses and institutions in every sector of the provincial economy that are responsible for more than one-quarter of all jobs in the province. Established in 1966, the Business Council is the foremost policy and business advocacy organization in the province.
A fourth generation British Columbian, Greg has played an active leadership role in business, politics and the community for over 25 years earning a reputation for results and building collaborative solutions that positively benefit companies, organizations and the lives of people that invest, live and work in BC.
During his career Mr D’Avignon has successfully led organizations and provided advice and practical policy solutions at senior levels within the Canadian government and within regulated and resource industries that have resulted in growth and economic benefit. He is a regular commentator on BC economic and policy issues and the chair of landmark forums on our Energy Future and LNG, First Nations Engagement and Investment, Trade and Economic Expansion with Asia , productivity and BC’s Future Prosperity.
Immediately prior to joining the Business Council, Mr D’Avignon was President, Western Canada, Canada’s National Brewers, having previously served as an advisor to the Prime Minister of Canada, and the Minister of National Defence and Minister of Justice.
Greg is active in his community, serving currently as a Board Member and Vice Chair of the British Columbia Cancer Foundation. He also recently served as the Chair of the Canadian Breast Cancer Foundation-BC/Yukon Region and on its National Board.
Greg is a 2013 recipient of the Queen’s Diamond Jubilee Medal for his contribution to the province. Greg also serves on the boards of several community, athletic, corporate and not-for-profit boards.
Todd Khozein: Partner, SecondMuse
Todd is a pioneer in systems innovation based on biological models. In this context, he has studied and applied systems theory to organizational innovation, developing systems in industries ranging from medicine to entertainment. His interests lie in creating collaborative frameworks where the incentive structure, technological platform and human resource development initiatives align to enable transfusion of innovation across hierarchy. At SecondMuse he has incorporated collaborative technology into these frameworks, founding initiatives such as RHoK and LAUNCH.
Ryan Wilson: CEO of Medeo
Ryan is the Chief Executive Officer of Medeo, Canada’s first direct-to-patient telehealth solution. Ryan Wilson graduated from UBC’s Sauder School of Business with a specialization in management of information systems. He is a certified information systems auditor with over 15 years of experience in delivering technology solutions including critical systems, web applications and infrastructure.
Ryan’s past experiences include co-founding Kubera Payments Corporation, a provider of payment processing services to companies in North America, and leading VersaPay (TSX VPY.V) as the director of technology where he designed and built Canada’s first real time electronic bill presentment and payment network.
Marco A. Marra: Director & Distinguished Scientist, Genome Sciences Centre, BC Cancer Agency
Dr. Marra completed his PhD in Genetics at Simon Fraser University in 1994 and subsequently worked as a postdoctoral fellow and research faculty instructor at Washington University in St. Louis. He has been involved in the development and application of efficient, high-throughput genomics approaches, with special emphasis on large-scale genome mapping and DNA sequencing. Current activities include the development and application of “next generation” sequencing approaches to characterize genomes, with the aim of comprehensive identification of the genetic changes that drive cancer progression. Dr. Marra is the UBC Canada Research Chair in Genome Science, and a member of the Order of British Columbia. He is a recipient of a 2012 UBC Faculty of Medicine Distinguished Achievement Award and the Medal of Merit Award from the International Association of Lions Club. He was elected to the Canadian Academy of Health Sciences in 2009; received the Frontiers in Research Award from the BC Innovation Council in 2008; and was appointed a Fellow of the Royal Society of Canada in 2007. He was a recipient of a Genome BC Award for Scientific Excellence, a Distinguished Achievement Award from UBC, a MSFHR Career Investigator Senior Scholar Award, and Simon Fraser University President’s 40th Anniversary Award. In 2004, he received a Terry Fox Young Investigator Award and BC Biotech’s Innovation and Achievement Award (together with the entire GSC staff) for sequencing the SARS coronavirus genome. Dr. Marra’s contributions to genome science led to an honorary Doctor of Science degree from Simon Fraser University in 2004, and an honorary Doctor of Laws degree from the University of Calgary in 2005. Dr. Marra has published 15 book chapters and 282 peer-reviewed papers.
Evi Mustel: President and Principal, Mustel Group
Evi Mustel is the co-founder and one of the principals of Mustel Group. She has over 30 years experience in the social and marketing research industry. Under her leadership, the company has grown to one of Western Canada’s most respected research companies.
Mustel is a familiar media personality, appearing regularly on television, radio and in newspapers commenting on research findings and current event issues. Well-known and respected for her research expertise, she has been a guest speaker and presented workshops at national and regional conferences to various industry organizations and regularly teaches marketing research classes at local colleges and universities.
With extensive experience conducting research in virtually every sector of business, Evi has specialized expertise in communications testing and tracking, public affairs, and customer/stakeholder satisfaction. A hallmark of Evi’s expertise is high-level, “big picture” analysis and creativity in finding novel approaches and efficient research solutions.
Ms Mustel has extensive experience in all aspects of primary research including study design, implementation and analysis of both quantitative and qualitative research, and in the full range of methodologies, including web, telephone, personal/on-site, mail, and multi-method/multi-phased.
Her clients include provincial, regional and municipal governments, federal government agencies, public corporations, not-for-profit organizations, business and professional associations. Evi has designed and conducted studies on many of today’s most important economic, environmental and social issues. These studies provide clients with input to strategic marketing, communications and policy decision-making.
Ms Mustel is a Certified Market Research Professional (CMRP). She holds a Bachelor of Arts (Honours) degree from McMaster University and is a Director with the YMCA of Greater Vancouver, EasyPark, Vancouver Board of Trade and past Chair of the Vancouver Board of Trade’s Women’s Leadership Circle Advisory Council. She holds membership in the Marketing Research and Intelligence Association (MRIA) and is a member of its Litigation and Regulatory Resource Committee.
Walter Robinson:Vice President, Government Affairs, Rx&D
Walter Robinson, re-joined Rx&D as Vice President of Government Affairs in August 2011 and is responsible for leading Rx&D’s integrated (federal and provincial) government affairs team. His key files include the Pan-Canadian Pricing Alliance (PCPA) along with the annual international BIO and Council of the Federation conferences. Prior to re-joining Rx&D, he was a Principal with Tactix Government Relations and Public Affairs in Ottawa from 2008 until 2011. He has also been self-employed as a writer, part-time broadcaster and business consultant. Over the last 20 years Walter has also worked for: the federal public service; an international facilities management contractor; as the federal director for the Canadian Taxpayers Federation (CTF) from 1997 to 2003 and as the Vice-President of Provincial Affairs for Rx&D in 2005 and 2006. He served as Chief of Staff to the Mayor of Ottawa until mid-2007. In his various roles, Walter has conducted over 10,000 media activities in the past decade. He has testified before federal, provincial and municipal legislative committees and has written over 300 published OPEDs which have appeared in the National Post, Globe and Mail and every regional daily newspaper in Canada. He also authored a 140-page critically acclaimed paper on healthcare reform which earned him a coveted first-day appearance (April 2002, Regina) before the Romanow Royal Commission on the Future of Health Care in Canada.
Jeffrey Betts: IBM Healthcare and Life Sciences
Jeff currently leads IBM’s Chronic Disease Management and Personalized Healthcare activities in Canada. He has over 30 years of management and project leadership experience, with seventeen of those years with IBM.
Before joining IBM, Jeff held various IT management positions in the BC provincial government, focused on creating, operating and expanding electronic services for citizens. Since joining IBM, he’s held positions with local, national and global responsibility, and has worked in Canada, the US, Australia, Europe and the Caribbean.
Since February 2011, when IBM’s ‘Watson’ computer was first showcased competing on ‘Jeopardy!’, Jeff has been leading IBM’s Canadian activities in adapting this Deep Question-Answering technology to the domain of decision support for physicians.
Alan Rabinowitz: Cardiologist, Co-founder and Chief Medical Officer, PHEMI Health Systems
Dr. Alan Rabinowitz is a cardiologist and President-elect of the Medical Staff of St Paul’s Hospital, Vancouver, and Clinical Associate Professor in the Division of Cardiology at the University of British Columbia. He is the co-founder of PHEMI Health Systems and serves as Chief Medical Officer and director on the board of the company. Dr Rabinowitz received his medical degree from the University of Cape Town, South Africa, completed his internal medicine and cardiology training at the University of Toronto and undertook subsequent training in interventional cardiology at St Paul’s Hospital. Dr. Rabinowitz serves as a special advisor to numerous medical institutions and organizations both locally and globally on medical innovation and system improvement.
In his capacity as Director of the Coronary Care Unit at St Paul’s Hospital, Dr. Rabinowitz recognized the critical importance of disruptive data solutions in transforming healthcare to enhance patient care, research and innovation, and improve sustainability of the healthcare ecosystem. This drove him to co-found PHEMI, a physician-driven health solutions company.
Dr. Julio Montaner: Director, BC Centre for Excellence in HIV/AIDS
Dr. Julio Montaner is the Director of the British Columbia Centre for Excellence in HIV/AIDS, the Chair in AIDS Research and Head of Division of AIDS in the Faculty of Medicine at UBC, and the Past-President of the International AIDS Society (IAS). His clinical research interests include HIV/AIDS, antiretroviral therapy, respiratory complications of HIV infection, salvage therapy in HIV/AIDS, multiple drug rescue therapy in HIV/AIDS, initiation of treatment in HIV/AIDS, treatment interruptions in HIV/AIDS, Therapeutic Drug Monitoring (TDM) in HIV/AIDS, pharmacology and drug interactions in HIV/AIDS, and the expansion of Highly Active Antiretroviral Therapy (HAART) to prevent transmission of HIV/AIDS. Julio Montaner’s recent research has been primarily focused on the implementation of the Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) initiative, which will utilize HIV treatment as an HIV prevention strategy in BC. The initiative seeks to drastically decrease HIV related morbidity and mortality in the province.
Paul V. Drohan: President & CEO, Life Sciences BC
Paul V. Drohan has over 25 years of experience in the global biopharmaceutical industry, and has recently returned from the United Kingdom where he lived and worked for the past eight years. Most recently, Paul was with Genzyme (a Sanofi Company) as Senior Global Vice President, leading the organization’s strategic, financial and sales and marketing operations performance for the U.K., Republic of Ireland, South Africa, Australia, New Zealand and Canada. Paul looks to bring this knowledge and experience back to Canada’s life sciences sector.
Bruce McManus: Professor, Department of Pathology and Laboratory Medicine, UBC
Bruce McManus is Professor, Department of Pathology and Laboratory Medicine, at the University of British Columbia. He serves as the CEO of the Centre of Excellence for Prevention of Organ Failure (PROOF Centre), and as Co-Director of the Institute for Heart + Lung Health. Dr. McManus served as the inaugural Scientific Director of the Institute of Circulatory and Respiratory Health, Canadian Institutes of Health Research, from 2000 until 2006.
Dr. McManus received BA and MD degrees at the University of Saskatchewan, an MSc from Pennsylvania State University, and PhD from the University of Toledo. He pursued post-doctoral fellowships at the University of California – Santa Barbara and at the National Heart, Lung, and Blood Institute in Bethesda, MD. Residency training was undertaken at the Peter Bent Brigham Hospital – Harvard University in Internal Medicine and Pathology.
Dr. McManus’ scholarly program is focused on mechanisms, consequences, detection and prevention of injury and aberrant repair involved in inflammatory diseases of the heart and blood vessels. He works in a cross-disciplinary setting on translational research questions for which answers are critically enabled by computational sciences including molecular biomarker discovery and validation, information acquisition, annotation, and use, and registry development to support heart and lung research. Dr. McManus has co-authored over 350 peer-reviewed publications, as well as many chapters. He has edited four books. He is co-holder of numerous patents. He has served as Councilor for the International Society for Heart Research and for the American Society for Investigative Pathology and as past-President of the Society for Cardiovascular Pathology. He currently serves on editorial boards of several professional and scientific journals, and on many advisory committees and boards. He has convened many public and private sector partnerships in research. Dr. McManus is a Fellow of the Royal College of Physicians and Surgeons of Canada, the College of American Pathologists, the American College of Cardiology, and the American College of Chest Physicians.
Among recognitions, Dr. McManus received the 2012 Milton Wong Leadership Award from LifeSciences BC, the 2012 Aubrey J. Tingle Prize from the Michael Smith Foundation for Health Research, and the 2012 Alumni Achievement Award from the University of Saskatchewan.
Enakshi Singh: Product Manager, SAP HANA Platform for Healthcare
Enakshi Singh is the product manager of the SAP HANA Platform for Healthcare. She works with multidisciplinary teams at SAP and collaborates with renowned genomic researchers to develop software solutions for real-time analyses of large-scale biological, lifestyle and clinical data. Enakshi received her M.Sc. in Neuroscience at McMaster University in Ontario, Canada. Her Masters’ thesis focused on the developmental distribution of the NMDA receptor in the auditory brainstem of rat. She also earned a BSc. in Psychology, Neuroscience and Behavior at McMaster University.
Alison Orth: Clinical Research Project Leader, Fraser Health Authority
Alison Orth is a Clinical Research Professional with over 18 years of experience conducting trials at community-based sites and a passion for quality, integrity and continuous improvement. Alison graduated with a Bachelor of Business Administration from Simon Fraser University in 1993. After graduation she worked as a Research Assistant at the Vaccine Evaluation Centre at BC Children’s Hospital. While there she discovered her keen interest in clinical research and found her way to TASC Research Services in Surrey. At TASC Alison assisted on vaccine trials until 1998 when she achieved her ACRP certification as a Clinical Research Coordinator. In 2002 Alison became Site Manager at TASC and then Vice President and Owner from 2006 to 2012. Along with a dedicated team of investigators, nurses, laboratory and research assistants Alison facilitated over 50 vaccine industry and public health clinical trials in Phases I-IV during her time at TASC. A variety of recruitment methods were utilized in order to successfully enroll and retain a range of 10-350 participants per trial in pediatric, adolescent, adult and senior populations. After TASC closed their doors in 2012, Alison began contracting with the BC Clinical Research Infrastructure Network (BCCRIN) on the Clinical Research Participation Survey and more recently the BC Online Asset Map. She is also employed by Fraser Health Authority as a Clinical Research Leader in Public Health and managing a C.difficile vaccine trial at two hospital sites. She currently serves on the working group of the nationwide Asset Map and the newly formed BCCRIN Recruitment and Retention Task Force and is dedicated to improving the clinical research environment within BC and Canada.
Simon Willams: CEO and co-founder, QuantumBlack
Simon Willams is Chief Executive and Co-Founder of QuantumBlack, a data science agency based in London, that blends strategy, analytics, engineering and design skills to help clients gain new intelligence from data, craft their strategic response to that intelligence and shape the organisations capabilities to deliver that response. QuantumBlack works internationally with some of the worlds most interesting organisations including Arup, Atkins, Boeing, Crossrail, McKinsey & Co, Microsoft, Standard & Poors, Thomson Reuters and several Formula One racing teams. Prior to QuantumBlack Simon led SmithBayes, a data-driven software firm spun-out from the Vodafone McLaren Mercedes Formula One racing team. Simon started his career in real-time trading systems at Reuters and then product management at ABN AMRO Bank.
Colin Hansen: Former Health and Finance Minister
Colin Hansen was first elected to the Legislative Assembly of British Columbia in 1996 to serve the constituency of Vancouver-Quilchena. He was reelected in the general elections of 2001, 2005, and 2009. Mr Hansen served as Minister of Finance and Deputy Premier (2008–11); Minister of Economic Development and Minister responsible for the Asia-Pacific Initiative and the Olympics (2005–8); Minister of Finance (2004–5); and Minister of Health Services (2001–4). Between 1996 and 2001, he served as health critic for the Official Opposition, as well as the critic for employment and investment, and for labour. Before his election to the legislature, Mr Hansen and his wife, Laura, ran a small business in Vancouver. He also served as vice-president of finance and administration for the Asia-Pacific Foundation of Canada. He has also been involved in a number of community organizations, having held such positions as director for the Vancouver-Yokohama Sister Society and chair of the Vancouver Museum board of trustees.
Andrew Wilkinson: MLA, Vancouver-Quilchena
Andrew Wilkinson was elected MLA in the riding of Vancouver-Quilchena in 2013, and was appointed the Minister of Technology, Innovation and Citizens’ Services on June 10, 2013. He is a former deputy minister of the British Columbia Ministry of Economic Development, where he had responsibility for economic issues, trade and tourism. He also served as deputy minister for Intergovernmental Relations in the Premier’s Office for two years. Prior to his election as MLA, Wilkinson worked as a lawyer in the Vancouver offices of a major national law firm, where he had a special interest in green renewable energy development. Prior to being called to the bar, Wilkinson was educated and licensed as a physician. He lived and worked as a doctor in Campbell River, Lillooet and Dease Lake.
Brad Popovich: Chief Scientific Officer, Genome British Columbia
Brad Popovich is Chief Scientific Officer at Genome British Columbia. He completed his MSc degree in Genetic Counseling from Sarah Lawrence College in 1978 and became one of the first genetic counselors to immigrate to Canada. He went on to complete an MSc and PhD in biochemical and molecular genetics respectively, at McGill University, completing his postdoctoral training in the laboratory of Nobel Laureate Oliver Smithies. During his graduate training period he was focused on the application of genomic technologies to the diagnosis and management of human disease. After completing his graduate and post doctoral training Brad became the founding director of the San Diego Children’s Hospital DNA Diagnostic Laboratory in 1989 and was responsible for the translation of several new genetic research findings into clinical practice. These genetic tests include: cystic fibrosis, Duchene muscular dystrophy, Becker muscular dystrophy, fragile X syndrome, and myotonic dystrophy. He was also a pioneer in the forensic use of DNA while in San Diego and his laboratory was the first in the US to offer solely DNA-based paternity testing.
Nancy Meagher: Executive Director, Population Data BC
Nancy Meagher has been the Executive Director of Population Data BC for the past eight years. With a Master’s in Economics, Nancy has worked internationally in health policy research, hospital management, and pharmaceutical market research, bridging research and its application in policy, business or industry. Her technical experience comes from work as a management consultant, where she led complex, privacy-sensitive development projects for companies including Goldman Sachs. Nancy has grown with Population Data BC, working with staff and key stakeholders to bring it from its inception as the Population Health and Learning Observatory, through integration with the BC Linked Health Database, expansion to include the Population Data Access and Analysis Platform, to its current structure as a single front door for research access: Population Data BC.